Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoporosis

Journal of Bone and Mineral Metabolism

Volumn 21, Issue 6, 2003, Pages 402-408

  Pennisi, Pietra ^a   Pizzarelli, Giuseppe ^a   Spina, Massimo ^a   Riccobene, Stefania ^a   Fiore, Carmelo Erio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

thalassemia major; Clodronate; Osteoporosis; Quantitative ultrasound of the heel

Indexed keywords

CALCIUM; CLODRONIC ACID; DEOXYPYRIDINOLINE; PLACEBO; VITAMIN D;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; BONE DENSITY; BONE DISEASE; BONE MASS; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FRACTURE; HUMAN; LIFE EXPECTANCY; MALE; MEASUREMENT; OSTEOPOROSIS; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; ULTRASOUND; URINARY EXCRETION;

ADULT; AMINO ACIDS; BETA-THALASSEMIA; BONE AND BONES; CALCIUM; CLODRONIC ACID; CREATINE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; OSTEOPOROSIS; TIME FACTORS; VITAMIN D;

EID: 0346363162     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-003-0435-5     Document Type: Article

References (35)

1. Vichinsky EP (1998) The morbidity of bone disease in thalassemia. Ann NY Acad Sci 850:344-348
2. Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldf AW (2000) Bone mineral metabolism in adults with beta-thalassemia major and intermedia. Br J Haematol 111:902-907
3. Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV, Wonke B (1998) High prevalence of low bone mass in thalassemia major. Br J Haematol 103:911-915
4. Pootrakul P, Hungspringss S, Fucharoens S, Baylink D, Thompson E, English E, Lee M, Burnell J, Finch C (1981) Relation between erythropoiesis and bone metabolism in thalassemia. New Engl J Med 304:1470-1473
5. El Hazmi Map, Wassy AS, Al Fawaz I (1994) Iron-endocrine pattern in patients with β-thalassemia. J Trop Pediatr 40:219-224
6. Lasco A, Morabito N, Gaudio A, Buemi M, Wasniewska M, Frisina N (2001) Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major. Osteoporosis Int 12:570-575
7. Perrotta S, Cappellini MD, Bertoldo F, Servedio V, Iolascon G, D'Agruma L, Gasparini P, Siciliani MC, Iolascon A (2000) Osteoporosis in beta-thalassemia major patients: analysis of genetic background. Br J Haematol 111:411-466
8. Lala R, Chiabotto P, Di Stefano M, Isaia GC, Garofalo F, Piga A (1998) Bone density and metabolism in thalassemia. J Pediatr Endocrinol Metab 11:785-790
9. Glüer CC, Wu Cy, Jergas M, Golgdstein SA, Genant HK (1994) Three quantitative ultrasound parameters reflect bone structure. Calcif Tissue Int 55:46-52
10. Hans D, Arlot ME, Schott Am, Roux JP, Kotzki PO, Meunier PJ (1995) Do ultrasound measuriments on the os calcis reflect more the bone microarchitecture that the bone mass? A two-dimensional histomorphometric study, Bone 16:295-300
11. Gonnelli S, Cepollaro C, Montagnani A, Martini S, Gennari L, Mangeli M, Gennari C (2000) Heel ultrasonography in monitoring alendronate therapy: a four-years longitudinal study. Osteoporosis Int 13:415-421
12. Molyvda-Athanasopoulou E, Sioundas A, Karatzas N, Aggellaki M, Pazaitou K, Vainas I (1999) Bone mineral density of patients with thalassemia major: four-years follow-up. Calcif Tissue Int 64:481-484
13. Alagna S, Mas ala A, Gallisai D, Ginanni A, Burrai C, Pinna A, Rovasio P, Devilla L (1992) Parathyroid function and bone metabolism in children with beta-thalassemia major: effects of sex steroid treatment. Eur J Med 1:153-157
14. Yates AJP, Percival RC, Gray RES, Atkins RM, Urwin GH, Hamdy NAT, Preston CJ, Beneton MNC, Russel RGG, Kanis JA (1985) Intravenous clodronate in the treatment and retreatment of Paget's disease of bone. Lancet i:1474-1477
15. Kanis JA (1987) Clodronate: a new perspective in the treatment of metabolic bone disease. Bone 8:1-86
16. Kanis JA, McClaskey EV, Paterson AHG (1990) Use of disphosphonates in hypercalcemia due to malignancy. Lancet i:170-171
17. Filipponi P, Cristallini R, Rizzello E, Policani G, Fedeli L, Gregorio F, Boldrini S, Traiani S, Massoni C (1996) Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long term clinical trial. Bone 18:179-184
18. Rossini M, Braga V, Gatti D, Gerardi D, Zamberlan N, Adami S (1999) Intramuscular clodronate therapy in postmenopausal osteoporosis. Bone 24:125-129
19. Lin JH (1996) Bisphosphonates: a review of their pharmacokinetic properties. Bone 18:75-85
20. Kang C, Speller R (1998) Comparison of ultrasound and dual-energy x-ray absorptiometry measurements in the calcaneus. Br J Radiol 71:861-867
21. Greenspan SL, Cheng S, Miller PD, Orwoll ES (2001) Clinical performance of a highly portable, scanning calcaneal ultrasonometer. Osteoporosis Int 12:391-398
22. Graafmans WC, Van Lingen A, Ooms ME, Bezemer PD, Lips P (1996) Ultrasound measurements in the calcaneus. Precision and its relation with bone mineral density of the heel, hip and lumbar spine. Bone 19:97-100
23. Fiore CE, Barone R, Pennisi P, Riccobene S (2002) Bone ultrasonometry, bone density, and turnover markers in type 1 Gaucher disease. J Bone Miner Metab 20:23-28
24. Glüer CC (1999) Monitoring skeletal changes by radiological techniques. J Bone Miner Res 14:1952-1962
25. Gnudi S, Lisi L, Fini M, Malavolta N (2001) Effect of intramuscular clodronate on bone and metabolism in osteoporotic women. Int J Tissue React 23:33-37
26. Morabito N, Lasco A, Gaudio A, Crisafulli A, Di Pietro C, Meo A, Frisina N (2002) Bisphosphonates in the treatment of thalassemia-induced osteoporosis. Osteoporosis Int 13:644-649
27. Filosa A, Di Maio S, Vocca S, Saviano A, Esposito G, Pagano L (1997) Longitudinal monitoring of bone mineral density in thalassemic patients. Genotype structure and osteoporosis. Acta Pediatr 86:342-346
28. Bagni B, Palazzi G, Bagni I, Caporali C, Froehlich W, Casolo A, Caputo C, Rossi S, Garetti E, Panzini F, Corazzari T, De Sanctis V, Massolo F (1998) pQCT (quantitative peripheral tomography) and date evaluation of phosphocalcic metabolism in thalassemic patients. J Pediatr Endocrinol Metab 11:791-794
29. Voskaridou E, Kyrtsonis MC, Terpos E, Skordili M, Theodoropoulos I, Bergele A, Diamanti E, Kalovidouris A, Loutradi A, Loukopoulos D (2001) Bone resorption is increased in young adults with thalassemia major. Br J Haematol 112:36-41
30. Parfitt A (1980) Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis. Miner Electrolyte Metab 11:273-287
31. Reeve J, Mitchell A, Tellez M, Hulme P, Green JR, Wardley-Smith B, Mitchell R (2001) Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis: prediction of long-term responses in spine and femur. J Bone Miner Metab 19:102-114
32. Del Puente A, Scognamiglio A, Itto E, Ferrara G, Oriente P (2000) Intramuscular clodronate in non responders to oral alendronate therapy for osteoporosis. J Rheumatol 27:1980-1983
33. Heckman G, Papaioannou A, Sebaldt RJ, Ioannidis G, Petrie A, Goldsmith C, Adachi JD (2002) Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates. Musculoskel Disord 3:1-6
34. Ruggiero L, De Sanctis V (1998) Multicentric study on prevalency of fractures in transfusion-dependent thalassemic patients. J Pediatr Endocrinol Metab 11:773-778
35. 3 therapy in a patient with McCune-Albright syndrome and accompanying hypophosphatemia. J Bone Miner Metab 20:170-173